Back to search

Finland· FI-REL-REL1965

Juvanesta Comp Vet

A penetamaattihydrojodidi, yhdistelmävalmisteet muiden bakteerilääkkeiden kanssa product containing penethamate hydriodide + dihydrostreptomycin sulfate, registered in Finland by Boehringer Ingelheim Danmark A/S. The same ATC class is registered in 2 of our 19 countries.

ATC QJ51RC25

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedJuvanesta Comp VetATCQJ51RC25REGISTER NO.FI-REL-REL1965PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Penethamate hydriodide + dihydrostreptomycin sulfate is registered in 2 of 19 countries.

Countries holding a registration under ATC QJ51RC25 (penetamaattihydrojodidi, yhdistelmävalmisteet muiden bakteerilääkkeiden kanssa), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Penethamate hydriodide + dihydrostreptomycin sulfate · ATC QJ51RC25

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Penethamate hydriodide + Dihydrostreptomycin sulfate
Manufacturer
Boehringer Ingelheim Danmark A/S
Country
Finland (FI)
ATC code
QJ51RC25
ATC class
Penetamaattihydrojodidi, yhdistelmävalmisteet muiden bakteerilääkkeiden kanssa
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/41fc207d-4533-470c-b1d7-a23f4ecef4e9
GET /v1/drugs/41fc207d-4533-470c-b1d7-a23f4ecef4e9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "intramammaarisuspensio",
  "route": "Maitorauhaseen",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Penetamaattihydrojodidi, yhdistelmävalmisteet muiden bakteerilääkkeiden kanssa",
  "ma_number": "9231",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1965",
  "authorised_at": "1986-02-12"
}

See everything about penethamate hydriodide + dihydrostreptomycin sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.